Related Experiment Video

Updated: Aug 16, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Promising switch to anastrozole for breast-cancer treatment

Vivien Chen

    The Lancet. Oncology
    |September 16, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    Related Experiment Videos

    Last Updated: Aug 16, 2026

    Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
    08:46

    Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

    Published on: September 16, 2021

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.

    Vaccine·2026

    Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia.

    Blood advances·2025

    Coma Blister After Trazodone Misuse: A Case Report.

    The American Journal of dermatopathology·2024

    Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.

    Journal of thrombosis and haemostasis : JTH·2023

    Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study.

    Research and practice in thrombosis and haemostasis·2023

    Looking beyond workforce parity: addressing gender inequity in pathology.

    Pathology·2023

    Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.

    The Lancet. Oncology·2026

    Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.

    The Lancet. Oncology·2026

    Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

    The Lancet. Oncology·2026

    Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

    The Lancet. Oncology·2026

    Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

    The Lancet. Oncology·2026

    Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

    The Lancet. Oncology·2026

    Gas tamponade choice in low-to-moderate complexity primary rhegmatogenous retinal detachment: propensity-matched comparisons of SF6, C2F6 and C3F8.

    The British journal of ophthalmology·2026

    SVF-Enriched Versus Standard Fat Grafting for Breast Reconstruction and Augmentation: A Prospective Multicenter Comparative Randomized Study.

    Aesthetic surgery journal·2026

    Long-Term Outcomes of Inverted-Bearing Reverse Shoulder Arthroplasty with Large Polyethylene Glenospheres.

    Journal of clinical medicine·2026

    Polyethylenimine/Graphene Oxide Nanocomposite for Lightweight X-Ray Radiation Shielding in Aerospace Applications.

    Materials (Basel, Switzerland)·2026

    Chemical Characterization and Migration Profile of Silicone Molds for Air Fryers.

    Polymers·2026

    Anesthesia inhalation agent sevoflurane induces perioperative cognitive impairment: Apelin/early growth response 1 axis induces ferritinophagy and exacerbates ferroptosis.

    Medical gas research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us